C.V.PHARMA
ActiveActs, filings and financial milestones
Deadline for the 2026 accounts:
2026
21-07
micro format · 10 days before the deadline
2025
31-08
micro format · 31 days late
2024
15-10
Gazette deed
IncorporationStarting capital €2,500 · Appointment: VRYGHEM Camille (director) · Founder9 points ▸
Gazette deed
Incorporation
Starting capital €2,500 · Appointment: VRYGHEM Camille (director) · Founder9 points ▸
- Incorporation, 11-10-2024
- Founding capital, €2,500
- Founder, VRYGHEM Camille
- Capital
- Registered office clause, “6211 Mellet, rue d'En-dessous, 41/E” (deed in French)
- Board rule, 1
- Director appointment, VRYGHEM Camille (director (not named in the articles))
- Other provision, “frais constitution”, 1487.12 (deed in French)
- Pre-incorporation commitments, “takeover, tous les engagements ainsi que les obligations qui en résultent, et toutes les activités entreprises” (deed in French)
Gazette deedNBB filing
Sources:Publications in the Belgian Official GazetteFilings with the National Bank